| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000260306.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021847964 |
Resistant |
| ENSG00000260306.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.043372326 |
Sensitive |
| ENSG00000260306.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.033295515 |
Sensitive |
